A detailed history of Essex Financial Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Essex Financial Services, Inc. holds 52,074 shares of BMY stock, worth $3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
52,074
Previous 61,211 14.93%
Holding current value
$3 Million
Previous $2.54 Million 5.98%
% of portfolio
0.13%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$39.66 - $51.75 $362,373 - $472,839
-9,137 Reduced 14.93%
52,074 $2.69 Million
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $106,139 - $139,734
-2,637 Reduced 4.13%
61,211 $2.54 Million
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $1.3 Million - $1.71 Million
32,236 Added 101.97%
63,848 $2.65 Million
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $99,894 - $113,260
-2,082 Reduced 6.18%
31,612 $1.71 Million
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $244,145 - $291,332
-5,036 Reduced 13.0%
33,694 $1.73 Million
Q3 2023

Nov 15, 2023

SELL
$57.89 - $64.73 $90,482 - $101,172
-1,563 Reduced 3.88%
38,730 $2.25 Million
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $219,926 - $244,194
-3,452 Reduced 7.89%
40,293 $2.58 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $48,625 - $55,152
740 Added 1.72%
43,745 $3.03 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $130,591 - $154,638
1,907 Added 4.64%
43,005 $3.09 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $6 - $3,918
51 Added 0.12%
41,098 $2.92 Million
Q2 2022

Aug 01, 2022

BUY
$72.62 - $79.98 $150,613 - $165,878
2,074 Added 5.32%
41,047 $3.16 Million
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $133,227 - $159,751
2,167 Added 5.89%
38,973 $2.85 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $115,304 - $134,418
-2,150 Reduced 5.52%
36,806 $2.3 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $274,193 - $321,182
4,634 Added 13.5%
38,956 $2.31 Million
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $28,245 - $31,768
-476 Reduced 1.37%
34,322 $2.17 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $46,018 - $52,147
797 Added 2.34%
34,798 $2.16 Million
Q3 2020

Nov 10, 2020

BUY
$57.43 - $63.64 $256,022 - $283,707
4,458 Added 15.09%
34,001 $2.05 Million
Q2 2020

Aug 06, 2020

SELL
$54.82 - $64.09 $322,396 - $376,913
-5,881 Reduced 16.6%
29,543 $1.74 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $247,868 - $360,211
-5,342 Reduced 13.1%
35,424 $1.98 Million
Q4 2019

Jan 30, 2020

BUY
$49.21 - $64.19 $744,399 - $971,002
15,127 Added 59.0%
40,766 $2.62 Million
Q3 2019

Nov 04, 2019

SELL
$42.77 - $50.71 $187,289 - $222,059
-4,379 Reduced 14.59%
25,639 $1.3 Million
Q2 2019

Jul 30, 2019

SELL
$44.62 - $49.34 $110,612 - $122,313
-2,479 Reduced 7.63%
30,018 $1.36 Million
Q1 2019

May 02, 2019

SELL
$45.12 - $53.8 $28,245 - $33,678
-626 Reduced 1.89%
32,497 $1.55 Million
Q4 2018

Feb 07, 2019

SELL
$48.76 - $63.23 $315,135 - $408,655
-6,463 Reduced 16.33%
33,123 $1.72 Million
Q3 2018

Nov 05, 2018

SELL
$55.19 - $62.25 $783,753 - $884,012
-14,201 Reduced 26.4%
39,586 $2.46 Million
Q2 2018

Aug 07, 2018

SELL
$50.53 - $62.98 $676,697 - $843,428
-13,392 Reduced 19.93%
53,787 $2.98 Million
Q1 2018

May 03, 2018

SELL
$59.92 - $68.98 $697,528 - $802,996
-11,641 Reduced 14.77%
67,179 $4.25 Million
Q4 2017

Feb 07, 2018

SELL
$59.94 - $65.35 $127,911 - $139,456
-2,134 Reduced 2.64%
78,820 $4.83 Million
Q3 2017

Nov 03, 2017

BUY
$55.23 - $63.74 $33,966 - $39,200
615 Added 0.77%
80,954 $5.16 Million
Q2 2017

Aug 07, 2017

BUY
N/A
80,339
80,339 $4.48 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Essex Financial Services, Inc. Portfolio

Follow Essex Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.